monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin in patients with metastatic
(2013), "A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin in patients with metastatic (mFOLFIRI) to or gastric adenocarcinoma refractory
( 2013 ), "A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil / leucovorin in patients with metastatic ( mFOLFIRI ) to or gastric adenocarcinoma refractory